National Medical Care Company (TADAWUL:4005)
Saudi Arabia
· Delayed Price · Currency is SAR 118.20
-0.80 (-0.67%)
Apr 29, 2026, 2:59 PM AST
TADAWUL:4005 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 1,600 | 1,294 | 1,082 | 917.93 | 845.38 | Upgrade
|
| Revenue Growth (YoY) | 23.71% | 19.59% | 17.85% | 8.58% | 4.50% | Upgrade
|
| Cost of Revenue | 1,017 | 847.98 | 714.93 | 630.99 | 601.08 | Upgrade
|
| Gross Profit | 582.88 | 445.7 | 366.85 | 286.95 | 244.3 | Upgrade
|
| Selling, General & Admin | 211.97 | 168.23 | 124.53 | 93.08 | 79.09 | Upgrade
|
| Other Operating Expenses | -1.4 | -6.33 | -4.03 | -8.35 | -8.19 | Upgrade
|
| Operating Expenses | 228.34 | 194.62 | 120.13 | 89.68 | 79.9 | Upgrade
|
| Operating Income | 354.54 | 251.08 | 246.72 | 197.27 | 164.4 | Upgrade
|
| Interest Expense | -26.97 | -22.74 | -3.5 | - | - | Upgrade
|
| Interest & Investment Income | 18.8 | 19.48 | 21.37 | 1.24 | - | Upgrade
|
| EBT Excluding Unusual Items | 346.36 | 247.83 | 264.59 | 198.5 | 164.4 | Upgrade
|
| Legal Settlements | - | 42.34 | - | - | - | Upgrade
|
| Pretax Income | 346.36 | 290.16 | 264.59 | 198.5 | 164.4 | Upgrade
|
| Income Tax Expense | 27.89 | -4.54 | 23.67 | 28.43 | 28.04 | Upgrade
|
| Net Income | 318.47 | 294.7 | 240.93 | 170.07 | 136.36 | Upgrade
|
| Net Income to Common | 318.47 | 294.7 | 240.93 | 170.07 | 136.36 | Upgrade
|
| Net Income Growth | 8.07% | 22.32% | 41.66% | 24.73% | 40.18% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Outstanding (Diluted) | 45 | 45 | 45 | 45 | 45 | Upgrade
|
| Shares Change (YoY) | -0.17% | -0.18% | - | - | - | Upgrade
|
| EPS (Basic) | 7.13 | 6.58 | 5.37 | 3.79 | 3.04 | Upgrade
|
| EPS (Diluted) | 7.13 | 6.58 | 5.37 | 3.79 | 3.04 | Upgrade
|
| EPS Growth | 8.25% | 22.54% | 41.66% | 24.73% | 40.18% | Upgrade
|
| Free Cash Flow | 26.8 | 136.63 | 412.73 | 185.83 | 61.61 | Upgrade
|
| Free Cash Flow Per Share | 0.60 | 3.05 | 9.20 | 4.14 | 1.37 | Upgrade
|
| Dividend Per Share | 3.000 | 2.000 | 2.000 | 1.000 | 1.000 | Upgrade
|
| Dividend Growth | 50.00% | - | 100.00% | - | - | Upgrade
|
| Gross Margin | 36.42% | 34.45% | 33.91% | 31.26% | 28.90% | Upgrade
|
| Operating Margin | 22.15% | 19.41% | 22.81% | 21.49% | 19.45% | Upgrade
|
| Profit Margin | 19.90% | 22.78% | 22.27% | 18.53% | 16.13% | Upgrade
|
| Free Cash Flow Margin | 1.68% | 10.56% | 38.15% | 20.24% | 7.29% | Upgrade
|
| EBITDA | 437.75 | 315.14 | 290.94 | 239.17 | 214.56 | Upgrade
|
| EBITDA Margin | 27.35% | 24.36% | 26.90% | 26.05% | 25.38% | Upgrade
|
| D&A For EBITDA | 83.21 | 64.06 | 44.22 | 41.9 | 50.16 | Upgrade
|
| EBIT | 354.54 | 251.08 | 246.72 | 197.27 | 164.4 | Upgrade
|
| EBIT Margin | 22.15% | 19.41% | 22.81% | 21.49% | 19.45% | Upgrade
|
| Effective Tax Rate | 8.05% | - | 8.95% | 14.32% | 17.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.